Industry Leaders
-
Considerations For The Use Of Wearables In Clinical Trials
2/1/2017
With wearables, we now have the means to innovate the “where” and the “how” of patient data capture, creating a 24-hour digital map of physical behaviors.
-
How To Increase Productivity Via Unconventional Hiring
1/1/2017
One of the most vexing and common problems HR professionals face is acquiring and training talent for specific skilled positions, only to see that talent, and the time and money invested in them, walk out the door too soon.
-
Meeting The Unknown Need In Pharma Labs
1/1/2017
The very nature of many scientific processes creates habitual behaviors. Often these habits are effectively passed from senior lab generations to younger ones. Old habits can be hard to break, especially in a time-pressured lab environment.
-
Active Targeting: A New Wave In Drug Delivery
11/1/2016
Although the history of drug development contains many stories of serendipitous discovery, critical advances often emerge by setting out to address specific challenges. Today, many challenges associated with older drugs are being solved with new delivery technologies.
-
The Space Squeeze: One Challenge In Building A Biopharm Lab
11/1/2016
Any biotech or life sciences company in Boston — early-stage or mature — is no stranger to Kendall Square’s lab space squeeze. As the top-performing lab market in the U.S., Kendall Square is especially sought after by life sciences companies — ranging from emerging startups to Big Pharma.
-
Great Expectations For Personalized Medicine Outside Oncology
9/1/2016
Oncology has always been the front runner in personalized medicine, so this is where targeted therapies and diagnostics have, for the most part, been focused. However, there is new activity outside this area where biomarker and targeted approaches are proving successful.
-
Life Sciences Companies Have Reason For Optimism In 2016
3/1/2016
Even though the U.S. economy continued to strengthen in 2015, many public investors sat on the sidelines grappling with global economic and political concerns and uncertainty surrounding the Fed’s policy concerning interest rates.
-
3 Keys To Successful Industry-Academic Collaborations
2/1/2016
Industry-academic collaborations are becoming more popular as pharmaceutical and biotechnology companies seek to harness the innovation and human capital within life sciences institutions.
-
How Lab Improvements Can Drive Productivity
2/1/2016
Today’s laboratory managers are facing significant budget cuts while simultaneously being challenged to obtain faster results. These pressures have created an increased focus on identifying potential areas of lab productivity improvement.
-
Strategic Financing Alternatives For Later-Stage Companies
1/1/2016
With the exception of several mega-financings for blue chip management teams in companies such as Juno and Denali from syndicates of well-heeled venture funds such as ARCH Ventures and Flagship Ventures, venture financing for startup life science companies has been relatively lean for the last several years.